Original Research
Accepted on 11 Nov 2025
Gemcitabine-cisplatin chemotherapy plus anti-PD-L1 therapy reinvigorates anti-tumor immune response by reprogramming the intrahepatic cholangiocarcinoma microenvironment
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 11 Nov 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 11 Nov 2025
in Cancer Genetics and Oncogenomics
Original Research
Accepted on 11 Nov 2025
in Green and Sustainable Chemistry
Original Research
Accepted on 11 Nov 2025
in Translational Medicine
Original Research
Accepted on 11 Nov 2025
in Precision Livestock Farming
Hypothesis and Theory
Accepted on 11 Nov 2025
in Translational Medicine
Hypothesis and Theory
Accepted on 11 Nov 2025
in Regulatory Science
Systematic Review
Accepted on 11 Nov 2025
in Periodontics
Original Research
Accepted on 11 Nov 2025
in Hematology
Methods
Accepted on 11 Nov 2025
in Animal Behavior and Welfare
Original Research
Accepted on 11 Nov 2025
in Clinical Nutrition
Brief Research Report
Accepted on 11 Nov 2025
in Neurodegeneration
Original Research
Accepted on 11 Nov 2025
in Musculoskeletal Aging
Systematic Review
Accepted on 11 Nov 2025
in Pediatric Dentistry
Original Research
Accepted on 11 Nov 2025
in Coral Reef Research
Review
Accepted on 11 Nov 2025
in Plant Abiotic Stress